Cardiol Therapeutics Inc.
Clinical-stage company developing anti-inflammatory and anti-fibrotic heart therapies.
CRDL | US
Overview
Corporate Details
- ISIN(s):
- CA14161Y2006
- LEI:
- Country:
- United States of America
- Address:
- 602-2265 UPPER MIDDLE ROAD EAST, OAKVILLE
- Website:
- https://www.cardiolrx.com/
- Sector:
- Manufacturing
Description
Cardiol Therapeutics Inc. is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The company's primary focus is on developing novel therapeutic approaches for underserved cardiovascular conditions by targeting the underlying mechanisms of inflammation and fibrosis. Its clinical programs are concentrated on significant and debilitating heart diseases, including recurrent pericarditis, myocarditis, and specific forms of heart failure. By collaborating with international researchers and clinicians, Cardiol Therapeutics aims to advance its pipeline of drug candidates to improve outcomes for patients suffering from these progressive syndromes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cardiol Therapeutics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cardiol Therapeutics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cardiol Therapeutics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
